Table 4.

Efficacy

Group	N	AE-IPF occurred within the 30th POD	Non–AE rate within the 30th POD	95 % CI	p-value
FAS	39	2	94.90 %	82.7–99.4	p = 0.010
PPS	36	1	97.20 %	85.5–99.9	p = 0.004
PPS-IPF	32	1	96.90 %	83.8–99.9	p = 0.008

AE-IPF acute exacerbation of idiopathic pulmonary fibrosis, POD postoperative day, FAS full analysis set, PPS per protocol set, PPS-IPF PPS excluding non-IPF cases diagnosed by the central review committee